Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug 4;1(1):1-8.
doi: 10.5414/ALX01285E. eCollection 2017.

Systemic therapy of atopic dermatitis

C Bußmann  1   2 , N Novak  2
Affiliations

Systemic therapy of atopic dermatitis

C Bußmann et al. Allergol Select. .

Abstract

Therapy of severe atopic dermatitis, which is refractory to consistent treatment with topical steroids and topical calcineurin inhibitors is still a problem in many cases. The use of cyclosporine, which is the only approved systemic drug for the therapy of severe atopic dermatitis, is often limited by contraindications or adverse reactions. In this context, results from controlled and open-label studies with novel therapeutic approaches such as methotrexate, omalizumab or rituximab, which are in part very promising, are of great interest. In this work we would like to provide an overview of established and new therapeutic options for the treatment of severe atopic dermatitis.

Keywords: antibiotics; atopic dermatitis; immunotherapy; systemic therapy.

PubMed Disclaimer

Republished from

  • pp. 164-171

Similar articles

See all similar articles

References

    1. Akdis CA Akdis M Bieber T Bindslev-Jensen C Boguniewicz M Eigenmann P Hamid Q Kapp A Leung DY Lipozencic J Luger TA Muraro A Novak N Platts-Mills TA Rosenwasser L Scheynius A Simons FE Spergel J Turjanmaa K Wahn U Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol. 2006; 118: 152–169. - PubMed
    1. Bangert CA Costner MI Methotrexate in dermatology. Dermatol Ther (Heidelb). 2007; 20: 216–228. - PubMed
    1. Belloni B Ziai M Lim A Lemercier B Sbornik M Weidinger S Andres C Schnopp C Ring J Hein R Ollert M Mempel M Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels. J Allergy Clin Immunol. 2007; 120: 1223–1225. - PubMed
    1. Benez A Fierlbeck G Successful long-term treatment of severe atopic dermatitis with mycophenolate mofetil. Br J Dermatol. 2001; 144: 638–639. - PubMed
    1. Berth-Jones J Finlay AY Zaki I Tan B Goodyear H Lewis-Jones S Cork MJ Bleehen SS Salek MS Allen BR Smith S Graham-Brown RA Cyclosporine in severe childhood atopic dermatitis: a multicenter study. J Am Acad Dermatol. 1996; 34: 1016–1021. - PubMed

LinkOut - more resources